Efe, G., Rustgi, A. K., & Prives, C. (2024). p53 at the crossroads of tumor immunity. Nature Cancer, 5(7), 983–995. https://doi.org/10.1038/s43018-024-00796-z

Guida, J. L., Hyun, G., Belsky, D. W., Armstrong, G. T., Ehrhardt, M. J., Hudson, M. M., Green, P. A., Robison, L. L., Streck, B. P., Tonorezos, E. S., Yasui, Y., Wilson, C. L., Wang, Z., & Ness, K. K. (2024). Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort. Nature Cancer, 5(5), 731–741. https://doi.org/10.1038/s43018-024-00745-w

Mellgard, G. S., Fojo, T., & Bates, S. E. (2024). Lessons from withdrawn accelerated approvals in oncology. Nature Cancer, 5(2), 211–215. https://doi.org/10.1038/s43018-023-00696-8

Rogava, M., Aprati, T. J., Chi, W.-Y., Melms, J. C., Hug, C., Davis, S. H., Earlie, E. M., Chung, C., Deshmukh, S. K., Wu, S., Sledge, G., Tang, S., Ho, P., Amin, A. D., Caprio, L., Gurjao, C., Tagore, S., Ngo, B., Lee, M. J., … Izar, B. (2024). Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nature Cancer, 5(3), 433–447. https://doi.org/10.1038/s43018-023-00704-x

Kumar, D., Gurrapu, S., Wang, Y., Bae, S.-Y., Pandey, P. R., Chen, H., Mondal, J., Han, H., Wu, C.-J., Karaiskos, S., Yang, F., Sahin, A., Wistuba, I. I., Gao, J., Tripathy, D., Gao, H., Izar, B., & Giancotti, F. G. (2024). LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nature Cancer, 5(2), 262–282. https://doi.org/10.1038/s43018-023-00695-9

Hart, S. F. M., Yonemitsu, M. A., Giersch, R. M., Garrett, F. E. S., Beal, B. F., Arriagada, G., Davis, B. W., Ostrander, E. A., Goff, S. P., & Metzger, M. J. (2023). Centuries of genome instability and evolution in soft-shell clam, Mya arenaria, bivalve transmissible neoplasia. Nature Cancer, 4(11), 1561–1574. https://doi.org/10.1038/s43018-023-00643-7

Su, Z., Kon, N., Yi, J., Zhao, H., Zhang, W., Tang, Q., Li, H., Kobayashi, H., Li, Z., Duan, S., Liu, Y., Olive, K. P., Zhang, Z., Honig, B., Manfredi, J. J., Rustgi, A. K., & Gu, W. (2023). Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism. Nature Cancer, 4(4), 564–581. https://doi.org/10.1038/s43018-023-00532-z

Migliozzi, S., Oh, Y. T., Hasanain, M., Garofano, L., D’Angelo, F., Najac, R. D., Picca, A., Bielle, F., Di Stefano, A. L., Lerond, J., Sarkaria, J. N., Ceccarelli, M., Sanson, M., Lasorella, A., & Iavarone, A. (2023). Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nature Cancer, 4(2), 181–202. https://doi.org/10.1038/s43018-022-00510-x

Zeleke, T. Z., Pan, Q., Chiuzan, C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., Mukhopadhyay, P., Kelly, S., Wu, R., Fenn, K., Trivedi, M. S., Accordino, M., Crew, K. D., Hershman, D. L., Maurer, M., … Silva, J. (2022). Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature Cancer, 4(2), 257–275. https://doi.org/10.1038/s43018-022-00489-5

Nobre, A. R., Dalla, E., Yang, J., Huang, X., Wullkopf, L., Risson, E., Razghandi, P., Anton, M. L., Zheng, W., Seoane, J. A., Curtis, C., Kenigsberg, E., Wang, J., & Aguirre-Ghiso, J. A. (2022). ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nature Cancer, 3(10), 1165–1180. https://doi.org/10.1038/s43018-022-00424-8

Boehm, K. M., Aherne, E. A., Ellenson, L., Nikolovski, I., Alghamdi, M., Vázquez-García, I., Zamarin, D., Long Roche, K., Liu, Y., Patel, D., Aukerman, A., Pasha, A., Rose, D., Selenica, P., Causa Andrieu, P. I., Fong, C., Capanu, M., Reis-Filho, J. S., Vanguri, R., … Shah, S. P. (2022). Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. Nature Cancer, 3(6), 723–733. https://doi.org/10.1038/s43018-022-00388-9

Lopez-Bujanda, Z. A., Haffner, M. C., Chaimowitz, M. G., Chowdhury, N., Venturini, N. J., Patel, R. A., Obradovic, A., Hansen, C. S., Jacków, J., Maynard, J. P., Sfanos, K. S., Abate-Shen, C., Bieberich, C. J., Hurley, P. J., Selby, M. J., Korman, A. J., Christiano, A. M., De Marzo, A. M., & Drake, C. G. (2021). Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer, 2(8), 803–818. https://doi.org/10.1038/s43018-021-00227-3

Arrieta, V. A., Chen, A. X., Kane, J. R., Kang, S. J., Kassab, C., Dmello, C., Zhao, J., Burdett, K. B., Upadhyayula, P. S., Lee-Chang, C., Shilati, J., Jaishankar, D., Chen, L., Gould, A., Zhang, D., Yuan, J., Zhao, W., Ling, X., Burks, J. K., … Sonabend, A. M. (2021). ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature Cancer, 2(12), 1372–1386. https://doi.org/10.1038/s43018-021-00260-2

Menolfi, D., & Zha, S. (2021). Targeting BRCA-mutated tumors in mitosis. Nature Cancer, 2(12), 1296–1297. https://doi.org/10.1038/s43018-021-00293-7